Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:

epcoritamab

epcoritamab
Drug Name Form Strength Infusion Center Available Restricted Non-formulary Ambulatory Available Interchange REMS
Epkinly SOLUTION, SUBCUTANEOUS bysp 4 mg/0.8 mL        
Epkinly SOLUTION, SUBCUTANEOUS bysp 48 mg/0.8 mL        
VIEW MORE Antineoplastic Agents
CLASS
100000
Additional Information and Links

OH Formulary

  • Indication: Treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B-cell lymphoma after two or more lines of systemic therapy
  • Service line: Hematology/Oncology
  • Formulary location: Inpatient, Outpatient infusion
  • Service location: Inpatient, Outpatient infusion
  • Patient population: Adult
  • Prior authorization required: Yes for outpatient
  • Restriction/criteria of use (all will apply unless specified):
    • Documented diagnosis of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including transformation of DLBCL from indolent lymphoma and high-grade B-cell lymphoma.
    • Have received two or more prior lines of therapy.
    • Patient must have ECOG performance status of 0-2.
    • Females of reproductive potential: negative pregnancy test.     
Last updated: Feb. 16, 2024

This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved